Healio
SearchLoading
Healio
SearchLoading

American Academy of Ophthalmology Meeting
ByCarl D. Regillo, MD
November 09, 2018
3 min watch
Save

VIDEO: Sustained-release ranibizumab ‘exceeds expectations’ for wet AMD

ByCarl D. Regillo, MD

CHICAGO — Carl D. Regillo, MD, gives an update on the phase 2 LADDER study, a four-arm trial of sustained-release ranibizumab (Genentech), at the American Academy of Ophthalmology meeting here.

Read more from American Academy of Ophthalmology Meeting

View all